Dr. Sean Michael Collon, MD

Dr. Collon practices at University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah.

Dr. Collon's NPI, 1033679840, was assigned on March 20, 2019. Dr. Collon graduated from Vanderbilt University School Of Medicine in 2019. Dr. Collon's California license number on file is A187813.

Dr. Collon's primary practice is University of Utah Hospitals and Clinics - Unit, at 50 North Medical Drive, Salt Lake City, UT 84132 in Salt Lake County. The practice phone is (801) 581-2337.

Dr. Collon's primary practice is University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah. Dr. Collon is also affiliated with University of Utah Hospital. The medical group on file is University of Utah Health. Dmand AI also links Dr. Collon to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Collon practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Collon's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dmand AI has Dr. Collon's licenses on file in 2 states: California and Utah.

Dmand AI lists conjunctivitis, dry eye, eyelid inflammation and vitreous eye degeneration among the conditions Dr. Collon treats.

CMS data shows 112 Medicare services from Dr. Collon across 3 procedure codes in 2024, for 135 Medicare patients. Medicare paid $3,094 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 135 Medicare patients who saw Dr. Collon in 2024. The largest group is 65 to 74, with 58 patients. 61% of them have high blood pressure, and 61% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.18, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Collon's median patient age at 72, with 52% women.

In 2024, Dr. Collon wrote 151 Medicare Part D claims for 69 patients. 61% of them were for generic drugs. CMS names the drug for 114 of them, across 4 drugs with 11 or more claims each, at $2,770 in total drug cost. In 2023, CMS named 42 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Collon for performance year 2024, reported as part of a group. Dr. Collon accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Collon in 2022. Dr. Collon's most frequent co-authors are David F. Chang, MD, David Myung, MD and Geoffrey C. Tabin, MD.

CMS Open Payments shows 23 general payments to Dr. Collon from 11 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 95% of the total. Alcon Laboratories Inc paid the most, $861.

Dr. Collon graduated from Vanderbilt University School Of Medicine in 2019.

Dr. Collon is in network with 16 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.